Table 3.
Reference | Study population | Study design | Main findings | Notes |
---|---|---|---|---|
Quinto et al28 | 32,321 children aged 5–17 years | Retrospective cohort study using electronic health records | Increased odds for multiple asthma exacerbation outcomes, including oral corticosteroid prescription: OR 1.21 (95% CI 1.13–1.29) for overweight; OR 1.28 (95% CI 1.21–1.36) for obese compared with normal weight children | Adjusted for demographics, parental education, asthma controller use and GERD |
Kattan et al23 | 386 minority adolescents aged 12–20 years | Sub-study of placebo-controlled randomized clinical trial | Females with a BMI above the 85th percentile had increased risk for exacerbations: OR 2.49, 95% CI 1.25–5.14 | 1-year clinical trial during which asthma medications were managed by asthma specialist |
Carroll et al29 | 884 ED visits for acute asthma, children aged 2–18 years | Retrospective chart review | Overweight children 1.76 times more likely to be admitted to hospital (95% CI 1.23–2.51) | Overweight defined as weight for age > 95th percentile, not BMI, because height measurements not routinely taken in ED |
Ginde et al30 | 672 children aged 5–17 years, presenting to ED for acute asthma | Multicenter prospective cohort study | No relationship between BMI and exacerbation severity | |
Carroll et al32 | 2009 children aged 2–18 years admitted to an ICU for acute asthma | Retrospective medical record review | Obese children had longer ICU length of stay (116 ± 12 hours vs 69 ± 57 hours, P = 0.02) and hospital length of stay (9.8 ± 7.0 days vs 6.5 ± 3.4 days, P < 0.01) | Similar severity of exacerbation at time of admission |
Abbreviations: BMI, body mass index; CI, confidence interval; ED, emergency department; GERD, gastroesophageal reflux disease; ICU, intensive care unit; OR, odds ratio.